
Find 52 companies with promising cash flow potential yet trading below their fair value.
To own Celanese, you need to believe it can convert its acetyl and engineered materials footprint into durable cash generation despite a tough chemical cycle. The latest quarter showed higher sales but weaker earnings, which keeps margin pressure and demand softness firmly in focus as the key near term catalyst and the biggest risk. The Amsterdam court win helps by removing a legal overhang, but it does not materially change the core earnings challenge.
Among recent announcements, the Amsterdam District Court decision is most relevant here. By dismissing the ethylene related damages and liability claims, it reduces uncertainty around potential cash outflows and balance sheet strain at a time when profits are under pressure. For investors watching Celanese’s elevated debt and interest burden, fewer legal contingencies can matter for confidence in future deleveraging and the company’s ability to fund its own recovery.
Yet against this improving legal backdrop, investors should still be aware that Celanese faces...
Read the full narrative on Celanese (it's free!)
Celanese's narrative projects $10.4 billion revenue and $799.7 million earnings by 2029. This requires 3.2% yearly revenue growth and about a $1.9 billion earnings increase from -$1.1 billion today.
Uncover how Celanese's forecasts yield a $68.70 fair value, a 57% upside to its current price.
Some of the most optimistic analysts once projected earnings near US$1.0 billion by 2029 and stronger margins, but weaker Q2 profits show how quickly those expectations could be challenged.
Explore 5 other fair value estimates on Celanese - why the stock might be worth just $63.62!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com